10.4155/fmc-2022-0309 25 ChiefariE.ArcidiaconoB.FotiD.BrunettiA
This installment also features FDA warning letters directed at Novo Nordisk and Eli Lilly
In recent years, the therapeutic footprint of this class has grown: long-acting agents (e.g., liraglutide, semaglutide) and next-generation dual/triple agonists (e.g., tirzepatide) have demonstrated superior glycemic control, weight reduction, and cardiovascular benefits in adults with T2DM (Yao et al., 2024)
Additionally, the gastrointestinal side effects common with GLP-1s (such as nausea, bloating, or diarrhea) can make hyperpalatable foods less appealing, creating a subtle but powerful disincentive
On the other hand, 5-amino-1MQ is more efficient and can save you money right away by speeding up processes